PCV36- COST-EFFECTIVENESS OF TREATING BY SIMVASTATIN 40 MG/DAY HIGH VASCULAR RISK PATIENTS- AN ECONOMIC EVALUATION BASED ON THE HEART PROTECTION STUDY
May 1, 2003, 00:00
10.1016/S1098-3015(10)64150-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)64150-2/fulltext
Title :
PCV36- COST-EFFECTIVENESS OF TREATING BY SIMVASTATIN 40 MG/DAY HIGH VASCULAR RISK PATIENTS- AN ECONOMIC EVALUATION BASED ON THE HEART PROTECTION STUDY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64150-2&doi=10.1016/S1098-3015(10)64150-2
First page :
Section Title :
Open access? :
No
Section Order :
353